CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,464 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03936985
NCT03936985N/ACompleted
CompareCT.gov

Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool

University of Utah·observational·Posted May 3, 2019·Updated Jul 11, 2024

In Brief

An observational study for Opioid Abuse and Prescription Drug Abuse (Not Dependent). Completed, enrolled 1,464 participants across 2 sites.

Detailed Summary

The goal of the study is to validate a Prescription Drug Monitoring Program-based opioid risk metric to discriminate between low, moderate, and high-risk opioid use disorder. The World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test (WHO ASSIST) will be used as the gold standard instrument that defines patient risk levels. No intervention or hypothesis will be tested.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Abuse, Prescription Drug Abuse (Not Dependent)
CountriesUnited States
CollaboratorsUniversity of Cincinnati, Purdue University, National Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 3, 2019
Enrollment StartNov 4, 2019
Primary CompletionAug 30, 2021
Study CompletionMay 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 7.2 years ago